Related Experiment Videos
Functional outcome after myocardial revascularization in ischemic left ventricular failure
G B Luciani1, G Montalbano, G Casali
1Division of Cardiac Surgery, University of Verona.
Summary
Coronary artery bypass grafting (CABG) improves survival in patients with severe left ventricular failure (LVEF < 30%). However, those with congestive heart failure experience poor symptom-free survival, necessitating further research.
Area of Science:
- Cardiology
- Cardiac Surgery
- Heart Failure Management
Background:
- Severe left ventricular failure (LVEF < 30%) presents a challenge in cardiac surgery.
- Coronary artery bypass grafting (CABG) offers survival rates comparable to heart transplantation in these patients.
- Functional outcomes after CABG in patients with severely reduced ejection fraction require detailed assessment.
Purpose of the Study:
- To evaluate the clinical results and functional outcomes of CABG in patients with LVEF < 30%.
- To compare outcomes between patients presenting with angina versus congestive heart failure.
Main Methods:
- Retrospective review of 101 consecutive patients undergoing CABG between 1/91 and 1/97.
- Stratification into two groups: 65 patients with angina (Group 1) and 36 with congestive heart failure (Group 2).
- Analysis of perioperative data, survival rates, and symptom-free survival during a mean follow-up of 29 months.
Main Results:
- Low perioperative mortality (1%) and comparable baseline characteristics between groups.
- Actuarial survival at 5 years was 74% for Group 1 and 78% for Group 2 (p=ns).
- Symptom-free survival at 5 years was significantly lower in the congestive heart failure group (28%) compared to the angina group (49%) (p=0.05), despite improvements in LVEF and functional class.
Conclusions:
- CABG improves survival in patients with ischemic left ventricular failure.
- Patients with congestive heart failure as the primary presentation experience unsatisfactory symptom-free survival post-CABG.
- Further studies are needed to define optimal treatment strategies (revascularization vs. transplantation) for this specific patient subgroup.